WHY CHOOSE ALIV

• ICU and pediatric-trained clinical staff.
• Founded by super-specialised doctors.
• Internationally sourced, pharmaceutical-grade compounds.
• Pioneers in regenerative medicine since 2015.
• Personalised programme design coordinated with your diabetologist and vascular surgeon.

HOW IT WORKS

Diabetic foot disease is multi-factor: hyperglycemia impairs every step of normal wound healing, microvascular disease reduces blood supply, neuropathy removes protective sensation, chronic inflammation persists. The protocol addresses each and adds regenerative growth factor delivery directly to the wound.

Layer 1: Workup.

Full ulcer characterisation (depth, size, infection, Wagner/IDSA stage), vascular assessment (ABI where indicated), neuropathy testing, HbA1c, lipid panel, kidney function, micronutrient status, infection screen.

Layer 2: PRP for Diabetic Foot (lead intervention).

Autologous platelet-rich plasma delivering PDGF, VEGF, TGF-β, EGF, FGF directly to the wound bed. Multiple SR/MAs of RCTs show PRP significantly improves DFU healing rate and shortens healing time vs conventional care alone. Applied as injection around wound margins or topical/gel application across the healing period.

Layer 3: Glycemic, Metabolic and Micronutrient Foundation.

Wound healing in diabetes is fundamentally dependent on glycemic control. Coordinates with the Advanced Metabolic Reset Protocol where appropriate (including Tirzepatide microdose pathway). Targeted micronutrient repletion: vitamin D, zinc, vitamin C, B-complex, protein adequacy.

Layer 4: Wound Care and Infection Management.

Standard wound care (debridement, advanced dressings, offloading) coordinated with your treating team. Active infection requires antibiotic management. Thymosin Alpha-1 can be added for clients with recurrent infections, immune dysregulation or stubborn slow-healing wounds.

Layer 5: Autologous Cell Therapy and Exosomes (selected advanced cases).

Investigational. Reserved for large chronic wounds, failed conventional approaches or post-amputation residual ulceration after PRP optimisation.

THE LIFESTYLE LAYER

Daily foot care and prevention are clinical interventions, not optional.

• Daily foot inspection: most ulcers begin from minor unnoticed injury.
• Footwear: diabetic-friendly with adequate depth, no internal seams, supportive insoles; custom orthotics for deformity.
• Skin and nail care: moisturise dry skin (not between toes); podiatry referral for callus or ingrown nail.
• Smoking cessation: dramatically worsens microvascular function. Non-negotiable.
• Glycemic discipline and offloading: medication adherence, regular monitoring, wound offloading during active healing.

PROTOCOL-RELATED FAQ

Q. How is this different from what my diabetologist or surgeon is already doing?

A. It complements, not replaces. Your diabetologist manages glycemic control; your surgeon manages wound debridement and surgical decisions. ALIV adds the regenerative layer (PRP for Diabetic Foot) plus integrated metabolic and lifestyle support.

Q. How strong is the evidence for PRP in diabetic foot ulcers?

A. Strong. Multiple meta-analyses of RCTs (the highest tier of clinical evidence) demonstrate that PRP significantly improves healing rate and shortens healing time compared to conventional care alone.

Q. Can PRP help me avoid amputation?

A. Honest answer: it can improve healing outcomes and may help avoid amputation in some cases, but it cannot guarantee that. PRP is most effective when introduced before tissue loss has progressed too far.

Q. What about my blood thinners?

A. Many diabetic patients are on antiplatelet or anticoagulant medication. PRP can usually still be performed but requires careful timing and physician coordination.

Q. Who should not do this protocol?

A. Active uncontrolled infection requiring inpatient management; critical limb ischemia requiring urgent vascular intervention; severe uncontrolled hyperglycemia requiring stabilisation first; clients seeking to bypass appropriate diabetology or surgical care.

Diabetic Foot Treatment in India, A Regenerative Multidisciplinary Approach

Diabetic foot ulcers are one of the most serious complications of diabetes, with a 6.2% pooled prevalence in Indian adults with diabetes. ALIV's Diabetic Foot Protocol layers PRP for Diabetic Foot (RCT-supported) onto glycemic optimisation, wound care and lifestyle support. Doctor-led at Pune and Mumbai.

What the Protocol Includes

Workup (ulcer staging, vascular and neuropathy assessment, micronutrient and infection screen), PRP for Diabetic Foot as lead intervention, glycemic and metabolic foundation (with Advanced Metabolic Reset coordination), wound care and infection management (with Tα1 for recurrent or immune-driven cases), and ACT or exosomes in selected advanced cases.

How ALIV Coordinates with Your Diabetology and Vascular Team

Integrative, not alternative. Active infection requires antibiotic management. Critical limb ischemia requires vascular surgery. All prescribed medications must continue as directed.

Who Should Consider This Protocol

Adults with active DFU, chronic non-healing wound, post-amputation residual ulceration, history of recurrent ulceration, or diabetic peripheral neuropathy with foot deformity.

Why Choose ALIV for Diabetic Foot Care in India

PRP for Diabetic Foot is one of the better-evidenced regenerative therapies in chronic wound care. ALIV combines it with the metabolic and lifestyle foundation that determines healing.

Frequently Asked Questions

How long is the protocol?

Depends on ulcer size, depth and healing rate. PRP sessions are coordinated across the healing period; follow-up at 3, 6 and 12 months.

Can I do this if I am on insulin?

Yes, with diabetology coordination.

Will I need vascular evaluation?

Yes, if pulses, ABI or clinical picture suggest vascular involvement.

Is PRP painful?

PRP injection involves a small needle pinch; topical/gel application is non-invasive.

Can PRP regrow lost tissue?

PRP accelerates healing and supports granulation and epithelialisation. It does not regrow lost bone or extensive missing tissue.